[Federal Register Volume 76, Number 18 (Thursday, January 27, 2011)]
[Notices]
[Page 4911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-1737]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee:

    Times and Dates:
    8 a.m.-6 p.m., February 23, 2011.
    8 a.m.-5 p.m., February 24, 2011.
    Place: CDC, Tom Harkin Global Communications Center, 1600 
Clifton Road, NE., Building 19, Kent ``Oz'' Nelson Auditorium, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters To Be Discussed: The agenda will include discussions on: 
immunization of healthcare personnel; Japanese encephalitis vaccine; 
13-valent pneumococcal conjugate vaccine; human papillomavirus (HPV) 
vaccines; human immunodeficiency virus (HIV); hepatitis B vaccine; 
pertussis vaccine; influenza; herpes zoster vaccine. Agenda items 
are subject to change as priorities dictate.
    Contact Person for More Information: Stephanie B. Thomas, 
National Center for Immunization and Respiratory Diseases, CDC, 1600 
Clifton Road, NE., Mailstop E-05, Atlanta, Georgia 30333, Telephone: 
(404) 639-8836, Fax: (404) 639-8905, e-mail [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention, 
and the Agency for Toxic Substances and Disease Registry.

    Dated: January 20, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-1737 Filed 1-26-11; 8:45 am]
BILLING CODE 4160-18-P